Patents for A61P 33 - Antiparasitic agents (21,787)
05/2003
05/27/2003US6569846 Photodynamic therapy and diagnosis and in vitro photodynamic killing of viruses and microorganisms
05/27/2003US6569463 Encapsulation coat includes different combinations of pharmaceutical active ingredients, hydrophilic and lipophilic surfactants, and triglycerides
05/27/2003US6569152 Sustained release delivery systems for solutes
05/27/2003CA2158455C Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide and their uses in vaccines and disease treatments
05/22/2003WO2003042377A1 Expansion of t cells in vitro and expanded t cell populations
05/22/2003WO2003042191A1 Benzamide and heteroarylamide as p2x7 receptor antagonists
05/22/2003WO2003042190A1 N-alkyl-adamantyl derivatives as p2x7-receptor antagonists
05/22/2003WO2003042184A1 Benzimidazol- or indol-aminoacetonitrile derivatives for parasite control
05/22/2003WO2003042147A1 Dihalogenpropene compounds, method for the production thereof, agents containing said compounds and the use thereof as pest control agents
05/22/2003WO2003041660A2 Solubilized topoisomerase poisons
05/22/2003WO2002100327A3 Substituted 1-benzazepines and derivatives thereof
05/22/2003WO2002044168A3 Indole-type inhibitors of p38 kinase
05/22/2003US20030097004 3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor antagonists
05/22/2003US20030096998 As immunomodulators and for inducing cytokine biosynthesis in animals, for therapy of viral infections
05/22/2003US20030096830 Pyrrolo(3,2-d)pyrimidin-7-yl)-1,4-imino-D-ribitol derivatives; for suppression of T-cell function
05/22/2003US20030096827 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition
05/22/2003US20030096822 Comprises moxidectin, praziquantel, benzyl alcohol, ethanol, colloidal silicon dioxide, surfactant, and oil; veterinary medicine
05/22/2003US20030096796 N-cyanomethyl amides which are cysteine protease inhibitors; use treating diseases associated with activity of cathepsins B, K, L or S such as autoimmune disorders, allergic disorder, allogeneic immune response, cardiovascular disorders
05/22/2003US20030096756 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/22/2003US20030096350 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/22/2003US20030096299 Natural ligand of G protein coupled receptor ChemR23 and uses thereof
05/22/2003US20030096297 Method for identifying inhibitors of G protein coupled receptor signaling
05/22/2003US20030095926 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
05/22/2003CA2466971A1 Benzimidazol- or indol-aminoacetonitrile derivatives for parasite control
05/21/2003EP1311694A1 Pyruvate:nadp+ oxidoreductase and uses thereof
05/21/2003EP1311677A2 Regulation of human p2y1-like g protein-coupled receptor
05/21/2003EP1311507A1 Fused pyrazole derivatives being protein kinase inhibitors
05/21/2003EP1311498A1 Diamino phenothiazine derivatives and composition comprising same
05/21/2003EP1311496A1 Heterocyclic fluoroalkenyl thioethers and the use thereof as pesticides (iii)
05/21/2003EP1311491A1 Use of triazinetrione sulfones for combating coccidiosis
05/21/2003EP1311475A1 Novel aminocyclohexane derivatives
05/21/2003EP1311288A1 Immunostimulatory nucleic acids for inducing a th2 immune response
05/21/2003EP1311271A1 Use of triazinetrione sulfoxides for controlling coccidioses
05/21/2003EP1009732B1 1-amino-alkylcyclohexane nmda receptor antagonists
05/21/2003EP0769959B1 Anti-protozoan methods and materials
05/21/2003CN1419588A A natural fluorescent dye obtained from a marine invertebrate, compositions from a marine invertebrate, compositions containing the said dye and their use
05/21/2003CN1419542A Heterocyclic acylsulfimides, a method for their production, agents containing the same and their use as pesticides 403
05/21/2003CN1109016C Synthetic polyunsaturated fatty acid analogues
05/20/2003US6566387 For therapy of psoriasis, atopic dermatitis, arthritis, asthma, chronic obstructive pulmonary disease, adult respiratory distress syndrome, inflammatory bowel disease, Crohn's disease, ulcerative colitis, stroke, septic shock
05/20/2003CA2132429C Alkylthio alkyl avermectins are active antiparasitic agents
05/15/2003WO2003040144A2 Heterocyclic compound based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds
05/15/2003WO2003040084A1 Unsaturated 1-amino-alkylcyclohexane nmda, 5ht3 and neuronal nicotinic receptor antagonists
05/15/2003WO2003039546A1 New uses for anti-malarial therapeutic agents
05/15/2003WO2003039533A1 Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases
05/15/2003WO2003039418A1 Compositions for the treatment of infectious diseases
05/15/2003WO2003039258A1 Pesticidal and parasitical di-and trifluorosubstituted alkene compounds
05/15/2003WO2002085303A3 Substituted tetracycline compounds for the treatment of malaria
05/15/2003WO2002064795A3 Putative human enzymes
05/15/2003US20030092894 Conjugated antigen for use as tool in the treatment of cancer
05/15/2003US20030092762 Anti-inflammatory nitro and thia-fatty acids
05/15/2003US20030092732 Eating disorders; dietetics; antiinflammatory agents; autoimmune diseases
05/15/2003US20030092712 Antiinflammatory agents; rheumatic diseases
05/15/2003US20030092705 Reverse malaria drug resistance
05/15/2003US20030092642 Diphosphate salt of a 4" -substituted-9-deoxo-9A-AZA-9A-homoerythromycin derivative and its pharmaceutical composition
05/15/2003US20030092640 Water, azalide compound, 25-75% propylene glycol, and acids
05/15/2003US20030092059 Human antibodies that bind human TNFalpha
05/15/2003US20030091630 Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
05/15/2003US20030091589 Veterinary medicine; feeding yeast cells
05/15/2003US20030091571 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
05/15/2003CA2466083A1 Compositions for the treatment of infectious diseases
05/14/2003EP1310493A1 N-adamantylalkyl benzamide derivates as p2x7-receptor antagonists
05/14/2003EP1309684A2 Polynucleotides and polypeptides encoded thereby
05/14/2003EP1309602A2 Malaria immunogen and vaccine
05/14/2003EP1309552A1 Compounds and inhibitors of phospholipases
05/14/2003EP1309320A2 Anthelminthic agents for the prevention of parasitic infections in humans and animals ii
05/14/2003EP0971589B1 Process and means for the eradication of fleas in the habitats of small mammals
05/14/2003EP0666919B1 Vaccine containing a thiol protease
05/14/2003CN1418215A Substituted beta-carbolines with IKB-kinase inhibiting activity
05/14/2003CN1418096A IL-8 receptor antagonists
05/14/2003CN1417329A Polyepitope malaria vaccine and its encoding gene
05/13/2003US6562806 Pyrrolobenzodiazepines
05/13/2003US6562792 Hygromycin derivatives
05/13/2003US6562785 Antimicrobial agent permeabilizes bacterial but not non-bacterial cell and is sufficient to transiently permeabilize the bacteria; toxic agent is only toxic upon entry into the antibiotic resistant bacteria
05/13/2003CA2080402C Avermectin compounds with a 6,5-spiroketal ring system and a 23-acyl substituent
05/08/2003WO2003038057A2 Genetic vaccine against human immunodeficiency virus
05/08/2003WO2003038043A2 Combinations of dr5 antibody and other therapeutic agents
05/08/2003WO2003037874A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles
05/08/2003WO2003037352A1 1-phenyl-5-n-heterocyclyl-pyrazoles as cyclooxygenase inhibitors for the treatment of inflammation associated disorders
05/08/2003WO2003037336A1 1-(5-sulfonyl-pyridin-2-yl)-5-(methylidene-cycloalkylmethoxy)-1h-pyrazole-4-carbonitrile derivatives and other compounds as cyclooxygenase inhibitors for the treatment of arthritis, neurodegeneration and colon cancer
05/08/2003WO2003037335A1 5-heteroatom-substituted pyrazoles
05/08/2003WO2003037164A2 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
05/08/2003WO2003012129A3 Shikimate kinase from s. aureus for drug discovery
05/08/2003WO2003006634A3 Use of oxidised lipoproteins for differentiation of precursor cells into mature dendritic cells
05/08/2003WO2002048097A9 Compounds, compositions and methods for treatment of parasitic infections
05/08/2003WO2002010216A3 Proteins and nucleic acids encoding same
05/08/2003US20030087895 Fused imidazole derivatives as multidrug resistance modulators
05/08/2003US20030087838 Mixture containing spinosyn a and d
05/08/2003US20030087816 Anticancer, antitumor agents; genetic engineering
05/08/2003CA2465367A1 Diagnosis and treatment of infectious diseases through indel-differentiated proteins
05/08/2003CA2465314A1 Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents
05/08/2003CA2465037A1 Genetic vaccine against human immunodeficiency virus
05/08/2003CA2464944A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles
05/07/2003EP1308447A1 Purine derivatives having antiproliferative properties and biological uses thereof
05/07/2003EP1308446A1 5-(alkylidene-cycloalkyl)- and 5-(alkylidene-heterocyclyl)-pyrazoles
05/07/2003EP1308445A1 5-heteroatom-substituted pyrazoles
05/07/2003EP1308444A1 Substituted 2-(2,6-Dioxo-3-Fluoropiperidine-3-YL)-Isoindolines and their use to reduce TNF-alpha Levels
05/07/2003EP1308163A1 Endoparasiticidal gel composition
05/07/2003EP1308161A1 5-N-heterocyclyl-1-(4-sulfonyl-phenyl)-1H-pyrazole derivatives with cyclooxygenase 2 (COX-2) inhibiting activity for the treatment of inflammatory diseases
05/07/2003EP1307559A2 Slit-like protein obtained from a cdna library from hs-5 stromal cell line
05/07/2003EP1307468A1 Macrolide antibiotics